We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic

News   Apr 22, 2008

 
Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
 
 
Advertisement
 

RELATED ARTICLES

New Process Accelerates Synthesis of Antiviral and Anticancer Drugs

News

Using a new process, scientists can create new nucleoside analogues months earlier than with the previous method, paving the way for quicker drug discoveries.

READ MORE

Team Determines Dose Threshold That Increases Delivery of Anticancer Drugs

News

A team of researchers has discovered a dose threshold that greatly increases the delivery of cancer-fighting nanoparticle drugs into a tumor.

READ MORE

Placebos Prove Powerful, Even When People Know They're Taking One, New Study Suggests

News

Researchers have demonstrated that placebos reduce brain markers of emotional distress even when people know they are taking one.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE